Embecta Corp. (EMBC): insider & executive buying
Embecta Corp. · Health Care · ref. ETF XLV · price $4.97
In short — 4 insiders bought Embecta Corp. over ~6 months (4 buys, total $558k, latest Aug 12, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Embecta Corp.'s executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$4.97-65.7% over range
Aug 28, 25low $2.9 · high $15.31Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 3 analysts
Latest insider buys on Embecta Corp.
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Aug 12, 26 | Kurdikar Devdatt | Pres, CEO | 30,000 | $141k |
| Aug 12, 26 | Elguicze Jacob | SVP, CFO | 20,000 | $93k |
| Aug 12, 26 | Mann Jeffrey Z | Pres, Pharm Svc, Prod Mgmt, CL | 20,000 | $100k |
| Aug 12, 26 | Hombach Robert J. | Dir | 45,000 | $224k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Embecta Corp.'s executives bought shares recently?
4 Embecta Corp. insider(s) bought $558k over ~6 months (latest Aug 12, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for EMBC?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Embecta Corp.? The JPI assistant answers using our backtest data.
Keep exploring Embecta Corp.